Skip to main content

Table 1 Most current available diagnostic tests for SARS-CoV 2

From: An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection

Approach Detection Mechanisms Advantages Disadvantages
RT-PCR Different genes (S, E, N, RdRp, ORF1ab) Reverse transcriptase PCR amplification (thermal cycles) High sensitivity and specificity with low copy number of virus False +/−, qualified technician, expensive, only in laboratory, only for active infection, uncomfortable swab sampling
LAMP, RT-LAMP, RPA Different genes (S, E, N, RdRp, ORF1ab) PCR amplification (without thermal cycle) Rapid screening (POC), time saving, user friendly, simple equipment Low sensitivity, False +, primary validation, only for active infection, uncomfortable swab sampling
CRISPR/cas Different genes (S, E, N, RdRp, ORF1ab) Detection and cleavages of viral RNA by CRISPR-cas9, 12, 13 systems Rapid screening (POC), time saving, user friendly, high specificity and sensitivity, read results by naked eye or simple instrument Low sensitivity due to viral adaptation, high cost
ELISA Viral Antigens (proteins)/antibodies Detection of Ag/Ab in the sample based on the attachment of anti-Ag/Ab and florescent visualization Quantitative detection, stable reagent, high sensitivity for Ab detection, can be visualized by using Au nanoparticles, low cost Less accuracy and low sensitivity especially in Ag detection at later phase of the disease, time consuming, high cost, difficult for early diagnosis in case of Ab detection
LFIA Viral antigens (proteins)/antibodies Detection of Ag or Ab in the plasma based on the attachment of antiAG/Ab on the nitrocellulose membrane and nanoparticle visualization Rapid screening (POC) and time saving, simple and user friendly, read the results by digital instrument or naked eye Less accuracy and low sensitivity, not suitable for early diagnosis, false nagative, verification needed
CLIA Viral antigens (proteins)/antibodies Detection of Ag or Ab in the plasma based on the attachment of anti-Ag/Ab on the magnetic, protein-coated microparticles and visualization by chemiluminescent Rapid screening (POC) and time saving, automated instruments High cost, not suitable for early diagnosis, need supporting chemiluminescence instruments
  1. Test are based on the detection of viral genes or proteins (Ag) or the presence of Antibodies in the patient’s sample that are mostly nasopharynx swabs or blood (plasma)
  2. LAMP loop-mediated isothermal amplification, POC point of care, ELISA enzyme linked immunosorbent assay, LFIA lateral flow immunoassay, CLIA chemiluminescent immunoassay; more details available at Nguyen et al. [136] and Kubina et al. [137]